These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8607724)

  • 21. Cost-effectiveness of HIV post-exposure prophylaxis in France.
    Herida M; Larsen C; Lot F; Laporte A; Desenclos JC; Hamers FF
    AIDS; 2006 Aug; 20(13):1753-61. PubMed ID: 16931940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of screening strategies for Gonorrhea among females in private sector care.
    Bernstein KT; Mehta SD; Rompalo AM; Erbelding EJ
    Obstet Gynecol; 2006 Apr; 107(4):813-21. PubMed ID: 16582117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Routine prenatal screening for HIV in a low-prevalence setting.
    Patrick DM; Money DM; Forbes J; Dobson SR; Rekart ML; Cook DA; Middleton PJ; Burdge DR
    CMAJ; 1998 Oct; 159(8):942-7. PubMed ID: 9834719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis.
    Plunkett BA; Grobman WA
    Am J Obstet Gynecol; 2005 Apr; 192(4):1153-61. PubMed ID: 15846195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of screening for HIV.
    Taiwo BO
    N Engl J Med; 2005 May; 352(20):2137-9; author reply 2137-9. PubMed ID: 15901873
    [No Abstract]   [Full Text] [Related]  

  • 26. Screening surgeons for HIV infection. A cost-effectiveness analysis.
    Owens DK; Harris RA; Scott PM; Nease RF
    Ann Intern Med; 1995 May; 122(9):641-52. PubMed ID: 7702225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection.
    Lurie P; Avins AL; Phillips KA; Kahn JG; Lowe RA; Ciccarone D
    JAMA; 1994 Dec; 272(23):1832-8. PubMed ID: 7990217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Routine screening for HIV infection--timely and cost-effective.
    Bozzette SA
    N Engl J Med; 2005 Feb; 352(6):620-1. PubMed ID: 15703428
    [No Abstract]   [Full Text] [Related]  

  • 29. HIV antibody screening among immigrants: a cost-benefit analysis.
    Zowall H; Fraser RD; Gilmore N; Deutsch A; Grover S
    CMAJ; 1990 Jul; 143(2):101-7. PubMed ID: 2114210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rational use of the HIV antibody test.
    Dwyer JM; Stewart GJ; McDonald P
    Med J Aust; 1993 Mar; 158(5):327-8. PubMed ID: 8474374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cost-benefit analysis of voluntary routine HIV-antibody testing for hospital patients.
    La Croix SJ; Russo G
    Soc Sci Med; 1996 May; 42(9):1259-72. PubMed ID: 8733196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Routine human immunodeficiency virus testing: an economic evaluation of current guidelines.
    Walensky RP; Weinstein MC; Kimmel AD; Seage GR; Losina E; Sax PE; Zhang H; Smith HE; Freedberg KA; Paltiel AD
    Am J Med; 2005 Mar; 118(3):292-300. PubMed ID: 15745728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How much should we pay for a new HIV diagnosis? A mathematical model of HIV screening in US clinical settings.
    Farnham PG; Sansom SL; Hutchinson AB
    Med Decis Making; 2012; 32(3):459-69. PubMed ID: 22247422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficiency and cost-effectiveness of dyslipidemia screening methods among workers in Bangkok.
    Sanguantrakul U; Jiamjarasrangsi W; Vimolket T
    Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):215-23. PubMed ID: 20578501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV testing for acute medical admissions: evaluation of a pilot study in Leicester, England.
    Palfreeman A; Nyatsanza F; Farn H; McKinnon G; Schober P; McNally P
    Sex Transm Infect; 2013 Jun; 89(4):308-10. PubMed ID: 23136079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholesterol, children, and heart disease: an analysis of alternatives.
    Berwick DM; Cretin S; Keeler E
    Pediatrics; 1981 Nov; 68(5):721-30. PubMed ID: 6796932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for human immunodeficiency virus in physicians. Who should we test and what will it cost.
    Levine AA; Sandler RS
    N C Med J; 1994 Apr; 55(4):136-40. PubMed ID: 8008080
    [No Abstract]   [Full Text] [Related]  

  • 38. Patterns of HIV testing at a London teaching hospital between 2004 and 2007.
    Madge S; Smith C; Evans A; Clewley G; Johnson MA; Geretti AM
    Int J STD AIDS; 2011 Dec; 22(12):730-3. PubMed ID: 22174055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing the costs of HIV screening strategies and technologies in health-care settings.
    Farnham PG; Hutchinson AB; Sansom SL; Branson BM
    Public Health Rep; 2008; 123 Suppl 3(Suppl 3):51-62. PubMed ID: 19166089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constant information is needed to prevent the spread of HIV-1 in Italy.
    Luzi G; Mezzaroma I; d'Offizi G; Valdarchi C; Aiuti F
    Allergol Immunopathol (Madr); 1991; 19(4):174-5. PubMed ID: 1818518
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.